AiViva Biopharma completes patient enrollment in phase 1 trial of AIV007 for age-related macular degeneration and diabetic macular edema

MLA

“AiViva Biopharma Completes Patient Enrollment in Phase 1 Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema.” PharmaBiz, Aug. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.806087402&authtype=sso&custid=ns315887.

APA

AiViva Biopharma completes patient enrollment in phase 1 trial of AIV007 for age-related macular degeneration and diabetic macular edema. (2024, August 26). PharmaBiz.

Chicago

PharmaBiz. 2024. “AiViva Biopharma Completes Patient Enrollment in Phase 1 Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema,” August 26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.806087402&authtype=sso&custid=ns315887.